Skip to main content
Premium Trial:

Request an Annual Quote

Cure Forward, Pharmatech Partner on Enrolling Patients in Cancer Clinical Trials

NEW YORK (GenomeWeb) – Cancer CRO Pharmatech and clinical trials matchmaker Cure Forward announced recently a collaboration to connect more patients to cancer-related clinical trials.

The partners will optimize Cure Forward's Clinical Trial Exchange system with plans by Pharmatech to eventually use the platform to recruit patients in its trials.

"Accessing Cure Forward's patient community complements our innovative site deployment capabilities, so that our investigators can enroll eligible participants and complete their studies," Pharmatech CEO Rob Bohacs said in a statement. The firm said that it can establish clinical trial sites in as little as 10 days.

The partners will optimize Clinical Trial Exchange in an initial collaboration phase, after which Pharmatech will become a commercial user of the platform to recruit patients to its advanced clinical trials, the firms said.

Since June, Cambridge, Massachusetts-based Cure Forward has collaborated with Paradigm, Cynvenio Biosystems, and Synbiodx to incorporate diagnostic tests in its clinical trial matchmaking platform.

The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.